ECM
SRNE

ExodusPoint Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

ExodusPoint Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44,233
Closed -$69K – 2310
2022
Q3 		$69K Buy
+44,233
New +$100K ﹤0.01% 1776
2022
Q2 		– Sell
-112,245
Closed -$262K – 2689
2022
Q1 		$262K Buy
+112,245
New +$350K ﹤0.01% 1813
2021
Q3 		– Sell
-76,327
Closed -$740K – 2851
2021
Q2 		$740K Buy
+76,327
New +$608K 0.01% 1158
2021
Q1 		– Sell
-50,000
Closed -$341K – 2774
2020
Q4 		$341K Sell
50,000
-9,886
-17% -$79.4K 0.01% 1471
2020
Q3 		$668K Buy
+59,886
New +$548K 0.02% 867
2019
Q2 		– Hold
0
– – – 1411
2019
Q1 		– Hold
0
– – – 792

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM